-
-
-
-
-
-
-
Galmed develops heart-targeted nanoparticle formulation of Aramchol
-
-
-
-
-
-
-
Galmed Pharmaceuticals terminates licensing deal, plans minority stake
-
-
-
-
-
-
-
Pre-Open Movers 06/20: (CLBS) (CLPS) (WGO) Higher; (LZB) (ORCL) (SBUX) Lower (more...)
-
-
-
-
-
-
-
Conatus (CNAT), Galmed (GLMD), Intercept (ICPT) Could Be Given Similar Considerations for their Assets - FBR
-
-
-
-
-
-
-
Market Wrap: Home Price Gains Lag in July; Starbucks to Buy Japan JV; Splitsville for Philips
-
-
1,185,616 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

